Tumor ablation therapy of liver cancers with an open magnetic resonance imaging-based navigation system
Takashi Maeda(Kyushu University), Makoto Hashizume(Kyushu University), Takanori Nakatsuji(Kyushu University), Jaesung Hong(Kyushu University), Yo‐ichi Yamashita(Kumamoto University), Akinobu Taketomi(Hokkaido University), Kazuo Tanoue(Kyushu University Hospital), Hideaki Nakashima(Fukuoka Dental College), Takefumi Yasunaga(Kyushu University), Kozo Konishi(Kyushu University), Yoshihiko Maehara(Kyushu University), Kazuhiro Kotoh(Kyushu University), Munechika Enjoji(Kyushu University)
Cited by 31
Related Papers
Interleukin‐6/<scp>STAT</scp>3 signaling as a promising target to improve the efficacy of cancer immunotherapy
|Cancer Science|2017|295
Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population
|The American Journal of Human Genetics|2012|272
Long‐term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi‐institutional Japanese study
|Journal of Hepato-Biliary-Pancreatic Sciences|2015|267
Randomized phase <scp>III</scp> study of gemcitabine, cisplatin plus S‐1 versus gemcitabine, cisplatin for advanced biliary tract cancer (<scp>KHBO1401</scp>‐ <scp>MITSUBA</scp>)
|Journal of Hepato-Biliary-Pancreatic Sciences|2022|244